Why Has Immuneel Therapeutics Raised Fresh Capital? Cancer-focused biotechnology startup Immuneel Therapeutics has secured more than ₹100 crore ($10.5 million) in a Series B funding round as it looks to … Continue reading Immuneel Raises ₹100 Crore Series B For Cancer Therapies